[go: up one dir, main page]

BRPI0911067B8 - métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido - Google Patents

métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido

Info

Publication number
BRPI0911067B8
BRPI0911067B8 BRPI0911067A BRPI0911067A BRPI0911067B8 BR PI0911067 B8 BRPI0911067 B8 BR PI0911067B8 BR PI0911067 A BRPI0911067 A BR PI0911067A BR PI0911067 A BRPI0911067 A BR PI0911067A BR PI0911067 B8 BRPI0911067 B8 BR PI0911067B8
Authority
BR
Brazil
Prior art keywords
methods
analyte
absence
systems
determining
Prior art date
Application number
BRPI0911067A
Other languages
English (en)
Inventor
C Curry Adam
Sandmann Christian
Weidemaier Kristin
Pederson Allphin Lori
Kuroda Melody
A Fulcher Robert
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of BRPI0911067A2 publication Critical patent/BRPI0911067A2/pt
Publication of BRPI0911067B1 publication Critical patent/BRPI0911067B1/pt
Publication of BRPI0911067B8 publication Critical patent/BRPI0911067B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54391—Immunochromatographic test strips based on vertical flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido nanopartículas revestidas compreendendo um núcleo envolvido por um invólucro que aumenta a refletância da nanopartícula, em que a nanopartícula revestida não inclui uma molécula ativa no raman, são fornecidas. dispositivos de teste e métodos de imunoensaio utilizando as nanopartículas revestidas são fornecidos.
BRPI0911067A 2008-04-09 2009-04-08 métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido BRPI0911067B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7103508P 2008-04-09 2008-04-09
US61/071.035 2008-04-09
PCT/US2009/039951 WO2009126735A1 (en) 2008-04-09 2009-04-08 Sensitive immunoassays using coated nanoparticles

Publications (3)

Publication Number Publication Date
BRPI0911067A2 BRPI0911067A2 (pt) 2015-12-29
BRPI0911067B1 BRPI0911067B1 (pt) 2020-10-20
BRPI0911067B8 true BRPI0911067B8 (pt) 2021-07-27

Family

ID=40756968

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911067A BRPI0911067B8 (pt) 2008-04-09 2009-04-08 métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido

Country Status (11)

Country Link
US (2) US20090305231A1 (pt)
EP (2) EP2952897B1 (pt)
JP (3) JP5792614B2 (pt)
CN (2) CN107561270B (pt)
AU (1) AU2009233755B2 (pt)
BR (1) BRPI0911067B8 (pt)
CA (1) CA2721064C (pt)
ES (2) ES2627190T3 (pt)
MX (1) MX2010011176A (pt)
TW (1) TW200946913A (pt)
WO (1) WO2009126735A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090291508A1 (en) * 2008-05-20 2009-11-26 Rapid Pathogen Screening Inc. Nanoparticles in diagnostic tests
US8470608B2 (en) * 2008-05-20 2013-06-25 Rapid Pathogen Screening, Inc Combined visual/fluorescence analyte detection test
US8669052B2 (en) 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US20110086359A1 (en) 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) * 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2012051218A2 (en) * 2010-10-11 2012-04-19 Mbio Diagnostics, Inc. Fluidic assay cartridge with controlled passive flow
US10114020B2 (en) 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
CA2778561C (en) * 2011-05-31 2020-10-13 Ghandi, Khashayar Magnetic nanocomposite material and processes for the production thereof
US9715579B2 (en) 2011-09-09 2017-07-25 Alverix, Inc. Distributed network of in-vitro diagnostic devices
US9524372B2 (en) 2011-09-09 2016-12-20 Alverix, Inc. In-vitro diagnostic device using external information in conjunction with test results
US10816492B2 (en) * 2012-01-31 2020-10-27 Regents Of The University Of Minnesota Lateral flow assays with thermal contrast readers
US10725033B2 (en) * 2012-01-31 2020-07-28 Regents Of The University Of Minnesota Lateral flow assays with thermal contrast readers
EP2884264B1 (en) 2012-08-10 2019-11-20 Hamamatsu Photonics K.K. Surface-enhanced raman scattering element, and method for producing same
JP6151948B2 (ja) 2013-03-29 2017-06-21 浜松ホトニクス株式会社 表面増強ラマン散乱ユニット及びラマン分光分析方法
WO2014025035A1 (ja) 2012-08-10 2014-02-13 浜松ホトニクス株式会社 表面増強ラマン散乱素子
EP2911791A4 (en) 2012-10-29 2016-11-02 Mbio Diagnostics Inc BIOPARTICLE IDENTIFICATION SYSTEM, CARTRIDGE AND RELATED METHODS
JP6359263B2 (ja) 2012-11-15 2018-07-18 オーソ・クリニカル・ダイアグノスティックス・インコーポレーテッド 流れモニタリングに基づく、側方流動アッセイ装置の品質／プロセス制御
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
WO2015184008A1 (en) 2014-05-27 2015-12-03 Academia Sinica Fucosidase from bacteroides and methods using the same
CA2950440A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-her2 glycoantibodies and uses thereof
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
CN106714829A (zh) 2014-05-28 2017-05-24 中央研究院 抗TNF‑α醣抗体及其用途
US11205757B2 (en) * 2014-11-06 2021-12-21 Sn Display Co., Ltd. Core-shell structured perovskite particle light-emitter, method of preparing the same and light emitting device using the same
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
EP3475409A4 (en) 2016-06-22 2020-03-04 Becton, Dickinson and Company MODULAR TEST READER
CN109963868B (zh) 2016-08-22 2023-11-14 醣基生医股份有限公司 抗体、结合片段及使用方法
US10796901B2 (en) * 2016-09-29 2020-10-06 Nanoco Technologies Ltd. Shelling of halide perovskite nanoparticles for the prevention of anion exchange
CN110554018A (zh) * 2018-05-31 2019-12-10 上海市刑事科学技术研究院 检测水溶液中4-溴甲卡西酮的表面增强拉曼材料及其制备方法
CN111686826B (zh) * 2019-03-15 2023-05-23 国家纳米科学中心 分层结构的微流控芯片及其应用
JP7607312B2 (ja) * 2020-01-09 2024-12-27 国立大学法人山梨大学 標識化シリカコート金ナノロッド及びその製造方法
US11376588B2 (en) 2020-06-10 2022-07-05 Checkable Medical Incorporated In vitro diagnostic device
TWI756764B (zh) * 2020-07-31 2022-03-01 國立中興大學 光電流電極及光電免疫感測裝置
WO2022179647A1 (en) * 2021-02-24 2022-09-01 Univerzita Palackeho V Olomouci Test strip for surface-enhanced raman spectroscopy, method for its preparation and use thereof
KR20230165290A (ko) 2021-04-01 2023-12-05 벡톤 디킨슨 앤드 컴퍼니 그룹 a 연쇄상구균 면역검정의 특이성 및 민감도를 향상시키기 위한 방법들
TWI792554B (zh) * 2021-09-10 2023-02-11 財團法人工業技術研究院 鈣鈦礦前驅物溶液檢測法
WO2023055305A1 (en) * 2021-09-28 2023-04-06 National Science And Technology Development Agency Qualitative dextran detection device and use thereof
CN114720450A (zh) * 2022-03-29 2022-07-08 中国工程物理研究院激光聚变研究中心 一种新冠病毒拉曼标记型抗原检测试纸条及其制备方法
CN115792216B (zh) * 2022-11-25 2023-11-03 中国农业科学院北京畜牧兽医研究所 用于检测毒素的侧向层析试纸条、制备方法和使用方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
USRE38430E1 (en) * 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
ATE195022T1 (de) * 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
CA1313616C (en) * 1987-06-01 1993-02-16 Robert B. Sargeant Lateral flow, non-bibulous membrane protocols
AU2684488A (en) * 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US6818199B1 (en) * 1994-07-29 2004-11-16 James F. Hainfeld Media and methods for enhanced medical imaging
CA2266747A1 (en) * 1996-09-25 1998-04-02 Mary Ann Childs Diagnostic test devices with improved fluid movement and resistance to interferences
US5998221A (en) 1996-09-25 1999-12-07 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US6194220B1 (en) * 1996-09-25 2001-02-27 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US5798273A (en) 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
EP1062510A2 (en) * 1998-03-10 2000-12-27 Strategic Diagnostics Inc. Integrated assay device and methods of production and use
US6136610A (en) * 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
WO2000031538A1 (en) * 1998-11-23 2000-06-02 Praxsys Biosystems, Inc. Improved lateral flow assays
WO2001018235A2 (en) * 1999-09-09 2001-03-15 Eichrom Technologies, Inc. Lateral flow device with metal oxide indicator and assay method employing same
EP1226422B1 (en) * 1999-10-06 2007-11-28 Oxonica Inc. Surface enhanced spectroscopy-active composite nanoparticles
US7052831B2 (en) 2000-09-29 2006-05-30 Becton Dickinson And Company Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device
ATE421570T1 (de) * 2002-06-07 2009-02-15 Cholestech Corp Automatisierte kassette für eine vorrichtung zur durchführung von immunoanalytischen tests und verfahren zu ihrer verwendung
ATE487941T1 (de) * 2003-03-10 2010-11-15 Sekisui Medical Co Ltd Verfahren zur untersuchung von proben und probenbehälter zur verwendung bei dem untersuchungsverfahren
EP1664783B1 (en) * 2003-09-23 2011-05-11 Epinex Diagnostic, Inc. Rapid test for glycated albumin
US20050148100A1 (en) * 2003-12-30 2005-07-07 Intel Corporation Methods and devices for using Raman-active probe constructs to assay biological samples
JP2006071520A (ja) * 2004-09-03 2006-03-16 Enbiotec Laboratories:Kk Ｐｃｂの簡易検出方法
US7723100B2 (en) * 2006-01-13 2010-05-25 Becton, Dickinson And Company Polymer coated SERS nanotag
US20090155811A1 (en) * 2006-01-27 2009-06-18 Oxonica, Inc. Lateral Flow Immunoassay With Encapsulated Detection Modality

Also Published As

Publication number Publication date
BRPI0911067B1 (pt) 2020-10-20
EP2952897B1 (en) 2017-03-22
AU2009233755A1 (en) 2009-10-15
CA2721064C (en) 2016-11-01
CN107561270A (zh) 2018-01-09
JP5792614B2 (ja) 2015-10-14
CN102016585B (zh) 2017-10-10
JP2011516889A (ja) 2011-05-26
US20090305231A1 (en) 2009-12-10
EP2271939A1 (en) 2011-01-12
JP2017015732A (ja) 2017-01-19
CN102016585A (zh) 2011-04-13
ES2544257T3 (es) 2015-08-28
CN107561270B (zh) 2019-06-04
MX2010011176A (es) 2011-02-24
BRPI0911067A2 (pt) 2015-12-29
CA2721064A1 (en) 2009-10-15
US20130281310A1 (en) 2013-10-24
EP2952897A1 (en) 2015-12-09
ES2627190T3 (es) 2017-07-27
EP2271939B1 (en) 2015-06-17
JP2015148629A (ja) 2015-08-20
JP6379149B2 (ja) 2018-08-22
AU2009233755B2 (en) 2015-11-26
TW200946913A (en) 2009-11-16
WO2009126735A1 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
BRPI0911067B8 (pt) métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido
BRPI0912751A2 (pt) métodos de análise e avaliação de um objeto com um sistema de laser de ultra som e instrumento para inspecionar um objeto.
MX2014003153A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
BRPI0720707A2 (pt) Sistema de teste para uso com um tampão para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; sistema de teste para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; e método de focalização de moléculas para facilitar um teste da presença de moléculas alvo de um ou mais tipos de alvo de uma amostra de teste biológico.
WO2009117168A3 (en) Detection of analytes using metal nanoparticle probes and dynamic light scattering
BR112012020251A2 (pt) dispositivo de análise para a aquisição de amostra, tratamento e reação
WO2009121032A3 (en) Sample preparation devices and methods for processing analytes
WO2014058760A3 (en) Preloaded test substrates for testing lal-reactive substances, methods of use, and methods of making
BRPI0911863A2 (pt) método para determinar a presença de um analito em uma amostra de estrutura queratinizada de um indivíduo.
WO2010065781A3 (en) Lateral flow strip assay with immobilized conjugate
MX350533B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
BR112012029281A2 (pt) anticorpo trop-2 anti-humano tendo atividade anti-tumor in vivo
CR20110241A (es) Método para inducir pluripotencia en células
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
WO2014060549A3 (en) Statistical linguistic analysis of source content
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
BRPI0912305A2 (pt) analisador químico, método para análise baseada em amostra, dispositivo para manipulação de cuvetas e método de carregamento.
BRPI1014652A2 (pt) sensor eletroquímico amperométrico, método para fabricar o mesmo, sonda amperométrica de medição do teor de uma substância de oxirredução dissolvida em um líquido e uso de um sensor.
WO2011088014A3 (en) Systems and methods for counting cells and biomolecules
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2008111464A1 (ja) スプライシング異常を指標とする抗ガン剤の作用検定方法
BR122019018448B8 (pt) método para extração de succinilacetona e um ou mais analitos biológicos adicionais
WO2007113838A3 (en) Device, system and method for in-vivo analysis
PT2129391E (pt) Método de diagnóstico
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO